| dc.contributor.author | Baylis, Françoise | |
| dc.contributor.author | Downie, Jocelyn | |
| dc.date.accessioned | 2013-02-11T17:34:07Z | |
| dc.date.available | 2013-02-11T17:34:07Z | |
| dc.date.issued | 2011-05-04 | |
| dc.identifier.citation | Baylis, F & Downie, J. (2011) Confusion worse confounded. British Medical Journal [Rapid Response: Withdrawal of clinical trials policy by Canadian research institute is a “lost opportunity for increased transparency” by Ann Silversides. British Medical Journal 2011;342:d2570]. Available at; http://www.bmj.com/content/342/bmj.d2570/reply | en_US |
| dc.identifier.issn | 0959-8138 | |
| dc.identifier.uri | http://hdl.handle.net/10222/15973 | |
| dc.description.abstract | Rapid response to "Withdrawal of clinical trials policy by Canadian research institute is a 'lost opportunity for increased transparency'" by Ann Silversides. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | BMJ Publishing | en_US |
| dc.relation.ispartof | British Medical Journal | |
| dc.subject | Stem Cell Research | en_US |
| dc.subject | CIHR clinical trials policy | |
| dc.title | Confusion worse confounded. British Medical Journal [Rapid Response: Withdrawal of clinical trials policy by Canadian research institute is a “lost opportunity for increased transparency” by Ann Silversides. British Medical Journal 2011;342:d2570]. | en_US |
| dc.type | Article | en_US |
| dc.identifier.volume | 342 | |
